化疗对卵巢的损伤及其当前保护方法
该综述批判性讨论环磷酰胺、顺铂和多柔比星等常见化疗药对卵巢尤其是卵泡的损伤机制及分子通路,并回顾保护性药物防止化疗所致卵泡丢失的机制;检索PubMed截至2019年3月的英文文献。
要点
- 环磷酰胺、顺铂和多柔比星通过诱导原始卵泡死亡和/或加速激活及生长卵泡闭锁增加,导致早发性卵巢功能不全。
- 化疗还增加血管和间质损伤并加重炎症。
- 近20年研究多种保护性化合物,但缺乏正在临床开发和测试的方法。
核心结论
- 环磷酰胺、顺铂和多柔比星通过诱导原始卵泡死亡和/或加速激活及生长卵泡闭锁增加导致早发性卵巢功能不全,并增加血管和间质损伤及炎症。
- 理解化疗药作用于卵巢各组分的机制,对开发高效靶向、保护和延长女性生育力的药物疗法至关重要。
- 虽临床前研究增多,但仍缺乏正在临床开发和测试的保护性辅助方法。
研究设计与样本
- 综述,检索PubMed截至2019年3月的英文文献,检索词包括ovary、fertility preservation、chemotherapy、follicle death、adjuvant therapy、cyclophosphamide、cisplatin、doxorubicin,并对保护性药物分析应用纳入和排除标准。
主要发现
- 近期研究显示化疗药可影响卵巢不同细胞组分,造成卵巢卵泡储备快速耗竭。
- 最常用三种药物环磷酰胺、顺铂和多柔比星通过诱导原始卵泡死亡和/或加速激活及生长卵泡闭锁增加导致早发性卵巢功能不全。
- 上述药物还增加血管和间质损伤并加重炎症。
- 近20年研究多种化合物作为潜在保护剂以对抗这些不良反应,本文讨论新近描述的保护性药物与这些损伤通路的相互作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anti-cancer therapy is often a cause of premature ovarian insufficiency and infertility since the ovarian follicle reserve is extremely sensitive to the effects of chemotherapy and radiotherapy. While oocyte, embryo and ovarian cortex cryopreservation can help some women with cancer-induced infertility achieve pregnancy, the development of effective methods to protect ovarian function during chemotherapy would be a significant advantage. OBJECTIVE AND RATIONALE: This paper critically discusses the different damaging effects of the most common chemotherapeutic compounds on the ovary, in particular, the ovarian follicles and the molecular pathways that lead to that damage. The mechanisms through which fertility-protective agents might prevent chemotherapy drug-induced follicle loss are then reviewed. SEARCH METHODS: Articles published in English were searched on PubMed up to March 2019 using the following terms: ovary, fertility preservation, chemotherapy, follicle death, adjuvant therapy, cyclophosphamide, cisplatin, doxorubicin. Inclusion and exclusion criteria were applied to the analysis of the protective agents. OUTCOMES: Recent studies reveal how chemotherapeutic drugs can affect the different cellular components of the ovary, causing rapid depletion of the ovarian follicular reserve. The three most commonly used drugs, cyclophosphamide, cisplatin and doxorubicin, cause premature ovarian insufficiency by inducing death and/or accelerated activation of primordial follicles and increased atresia of growing follicles. They also cause an increase in damage to blood vessels and the stromal compartment and increment inflammation. In the past 20 years, many compounds have been investigated as potential protective agents to counteract these adverse effects. The interactions of recently described fertility-protective agents with these damage pathways are discussed. WIDER IMPLICATIONS: Understanding the mechanisms underlying the action of chemotherapy compounds on the various components of the ovary is essential for the development of efficient and targeted pharmacological therapies that could protect and prolong female fertility. While there are increasing preclinical investigations of potential fertility preserving adjuvants, there remains a lack of approaches that are being developed and tested clinically.
引用
- Spears N, Lopes F, Stefansdottir A, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019. PMID: 31600388. doi:10.1093/humupd/dmz027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。